Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRB
· Real-Time Price · USD
9.60
1.18 (14.01%)
At close: Jun 25, 2025, 3:42 PM
14.01% (1D)
| Bid | 9.45 |
| Market Cap | 83.87M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 72.95M |
| EPS (ttm) | -7.95 |
| PE Ratio (ttm) | -1.21 |
| Forward PE | -0.93 |
| Analyst | Hold |
| Ask | 9.77 |
| Volume | 176,077 |
| Avg. Volume (20D) | 98,854 |
| Open | 8.34 |
| Previous Close | 8.42 |
| Day's Range | 8.16 - 9.77 |
| 52-Week Range | 6.53 - 30.60 |
| Beta | 2.62 |
About MCRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MCRB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MCRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-16.04%
Seres Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
6 months ago
+3.83%
Seres Therapeutics shares are trading higher after the company announced that SER-155 received FDA breakthrough therapy designation for its bloodstream infection reduction.
